Actively Recruiting
Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger
Led by Konya Beyhekim Training and Research Hospital · Updated on 2026-03-19
60
Participants Needed
1
Research Sites
61 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients aged 18-75 years who present with trigger finger to a tertiary rehabilitation hospital and agree to participate will be included in the study. Participants will be randomly allocated into three groups using block randomization. The first group will use a static finger splint that blocks the proximal interphalangeal joint for 6 weeks, along with a home exercise program. The second group will receive paraffin bath therapy, and the third group will receive peloidotherapy, both in combination with home exercises. All patients will receive education about the disease and activity modification. The finger joint-restricting splint and exercises will be applied for 6 weeks. Evaluations will be conducted at baseline, at the end of the 3rd week, and at the end of the 6th week by a blinded assessor. No analgesic or anti-inflammatory medication will be permitted during the study, and patients will be instructed to avoid using analgesics within 24 hours prior to each assessment.
CONDITIONS
Official Title
Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be between 18 and 75 years old and willing to participate
- Have a diagnosis of idiopathic single trigger finger, Grade 2 or 3
You will not qualify if you...
- Triggering in more than one finger
- Triggering at the A3 pulley or Grade 1 or Grade 4 trigger finger
- Thumb (pollex) trigger finger
- Injection or release surgery for trigger finger within the past 6 months
- Physical therapy for the hand within the past 6 months
- Current use of corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs)
- Inflammatory or autoimmune rheumatologic diseases such as rheumatoid arthritis, lupus, gout, or psoriatic arthritis
- Other musculoskeletal disorders (e.g., carpal tunnel syndrome, de Quervain's tenosynovitis, hand osteoarthritis, Dupuytren's contracture) or neurological diseases affecting the same hand
- Musculoskeletal disorders causing pain or limitation in the proximal upper extremity on the affected side
- Significant metabolic diseases like hypothyroidism, Cushing's syndrome, or uncontrolled diabetes
- Conditions interfering with treatment such as open wounds, rashes, infections, or active malignancy of the hand
- History of chronic or repetitive hand trauma
- Unwillingness to complete self-assessment questionnaires
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Konya Beyhekim Training and Research Hospital
Konya, Konya, Turkey (Türkiye), 42080
Actively Recruiting
Research Team
R
Ramazan Yilmaz, Assoc Prof (MD)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here